Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Klapproth

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cellular Signalling|November 25, 2021
Function and regulation of phosphatase 1 in healthy and diseased heartErik Klapproth, Susanne Kämmerer, Ali El-Armouche
Pflugers Archiv : European Journal of Physiology|November 27, 2024
Correction to: Intertwined regulators: hypoxia pathway proteins, microRNAs, and phosphodiesterases in the control of steroidogenesisStephen Ariyeloye, Susanne Kämmerer, Erik Klapproth, et al.
Pflugers Archiv : European Journal of Physiology|February 14, 2024
Intertwined regulators: hypoxia pathway proteins, microRNAs, and phosphodiesterases in the control of steroidogenesisStephen Ariyeloye, Susanne Kämmerer, Erik Klapproth, et al.
Zeitschrift Fur Rheumatologie|January 27, 2026
[Why C-reactive protein is (usually) not high in SLE]Erik Klapproth, Martyna Hempel, Nicolai Leuchten, et al.
Oncotarget|May 18, 2017
Adhesion- and stress-related adaptation of glioma radiochemoresistance is circumvented by β1 integrin/JNK co-targetingAnne Vehlow, Erik Klapproth, Katja Storch, et al.
Oncotarget|May 3, 2018
Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and β1 integrin inhibitionErik Klapproth, Ellen Dickreuter, Falk Zakrzewski, et al.
Basic Research in Cardiology|September 18, 2025
The CNP analogue vosoritide mediates PDE2-sensitive anti-arrhythmogenic effects in mouse hearts with STZ-induced type 1 diabetesRebecca Firneburg, Katharina Tergau, Eleder Cachorro, et al.
Basic Research in Cardiology|April 27, 2026
Publisher Correction: The CNP analogue vosoritide mediates PDE2-sensitive anti-arrhythmogenic effects in mouse hearts with STZ-induced type 1 diabetesRebecca Firneburg, Katharina Tergau, Eleder Cachorro, et al.
Cell Reports|March 28, 2019
Interaction of Discoidin Domain Receptor 1 with a 14-3-3-Beclin-1-Akt1 Complex Modulates Glioblastoma Therapy SensitivityAnne Vehlow, Erik Klapproth, Sha Jin, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 19, 2021
Systemic mesalazine treatment prevents spontaneous skin fibrosis in PLK2-deficient miceManja Newe, Theresa A Kant, Maximilian Hoffmann, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cellular Signalling|November 25, 2021
Function and regulation of phosphatase 1 in healthy and diseased heartErik Klapproth, Susanne Kämmerer, Ali El-Armouche
Pflugers Archiv : European Journal of Physiology|November 27, 2024
Correction to: Intertwined regulators: hypoxia pathway proteins, microRNAs, and phosphodiesterases in the control of steroidogenesisStephen Ariyeloye, Susanne Kämmerer, Erik Klapproth, et al.
Pflugers Archiv : European Journal of Physiology|February 14, 2024
Intertwined regulators: hypoxia pathway proteins, microRNAs, and phosphodiesterases in the control of steroidogenesisStephen Ariyeloye, Susanne Kämmerer, Erik Klapproth, et al.
Zeitschrift Fur Rheumatologie|January 27, 2026
[Why C-reactive protein is (usually) not high in SLE]Erik Klapproth, Martyna Hempel, Nicolai Leuchten, et al.
Oncotarget|May 18, 2017
Adhesion- and stress-related adaptation of glioma radiochemoresistance is circumvented by β1 integrin/JNK co-targetingAnne Vehlow, Erik Klapproth, Katja Storch, et al.
Oncotarget|May 3, 2018
Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and β1 integrin inhibitionErik Klapproth, Ellen Dickreuter, Falk Zakrzewski, et al.
Basic Research in Cardiology|September 18, 2025
The CNP analogue vosoritide mediates PDE2-sensitive anti-arrhythmogenic effects in mouse hearts with STZ-induced type 1 diabetesRebecca Firneburg, Katharina Tergau, Eleder Cachorro, et al.
Basic Research in Cardiology|April 27, 2026
Publisher Correction: The CNP analogue vosoritide mediates PDE2-sensitive anti-arrhythmogenic effects in mouse hearts with STZ-induced type 1 diabetesRebecca Firneburg, Katharina Tergau, Eleder Cachorro, et al.
Cell Reports|March 28, 2019
Interaction of Discoidin Domain Receptor 1 with a 14-3-3-Beclin-1-Akt1 Complex Modulates Glioblastoma Therapy SensitivityAnne Vehlow, Erik Klapproth, Sha Jin, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 19, 2021
Systemic mesalazine treatment prevents spontaneous skin fibrosis in PLK2-deficient miceManja Newe, Theresa A Kant, Maximilian Hoffmann, et al.
Pageof 3